XML 77 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
12 Months Ended
Dec. 31, 2011
Income Taxes [Abstract]  
Income Taxes

T. Income Taxes

The components of income (loss) from continuing operations before income taxes were as follows:

 

      2011     2010     2009  

U.S.

   $ (98   $ (403   $ (512

Foreign

     1,161        951        (986
     $ 1,063      $ 548      $ (1,498

The provision (benefit) for income taxes on income (loss) from continuing operations consisted of the following:

 

2011     2010     2009  

Current:

      

Federal*

   $ 10      $ 33      $ (119

Foreign

     427        409        142   

State and local

     (1     (7     (1
       436        435        22   

Deferred:

      

Federal*

     28        37        (89

Foreign

     (211     (320     (510

State and local

     2        (4     3   
       (181     (287     (596

Total

   $ 255      $ 148      $ (574

Included in discontinued operations is a tax benefit of $1 in 2011, $3 in 2010, and $55 in 2009.

The exercise of employee stock options generated a tax benefit of $6 in 2011 and $2 in 2010, representing only the amount realized for the difference between compensation expense recognized for financial reporting and tax purposes. These amounts increased equity and reduced current taxes payable in their respective periods. There were no exercises of employee stock options in 2009.

Alcoa also has unamortized tax-deductible goodwill of $179 resulting from intercompany stock sales and reorganizations (generally at a 30% to 34% rate). Alcoa recognizes the tax benefits associated with this tax-deductible goodwill as it is being amortized for local income tax purposes rather than in the period in which the transaction is consummated.

 

A reconciliation of the U.S. federal statutory rate to Alcoa's effective tax rate for continuing operations was as follows (the effective tax rate for both 2011 and 2010 was a provision on income and for 2009 was a benefit on a loss):

 

2011     2010     2009  

U.S. federal statutory rate

     35.0     35.0     35.0

Taxes on foreign operations

     (8.4     (3.5     (4.8

Permanent differences on restructuring charges and asset disposals

     -        0.7        1.1   

Audit and other adjustments to prior years' accruals

     (1.1     1.2        (0.7

Noncontrolling interests

     0.8        2.6        -   

Statutory tax rate and law changes

     0.8        (5.1     4.2   

Reorganization of equity investment

     -        -        4.7   

Items related to smelter operations in Italy*

     -        -        (9.3

Tax law change related to Medicare Part D

     -        14.4        -   

Release of valuation allowances

     (0.3     (10.6     2.3   

Amortization of goodwill

     (2.8     (5.2     3.5   

Other

     -        (2.6     2.3   

Effective tax rate

     24.0     26.9     38.3

On March 23, 2010, the Patient Protection and Affordable Care Act (the "PPACA") was signed into law, and, on March 30, 2010, the Health Care and Education Reconciliation Act of 2010 (the "HCERA" and, together with PPACA, the "Acts"), which makes various amendments to certain aspects of the PPACA, was signed into law. The Acts effectively change the tax treatment of federal subsidies paid to sponsors of retiree health benefit plans that provide prescription drug benefits that are at least actuarially equivalent to the corresponding benefits provided under Medicare Part D.

Alcoa pays a portion of the prescription drug cost for eligible retirees under certain postretirement benefit plans. These benefits were determined to be actuarially equivalent to the Medicare Part D prescription drug benefit of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the "MPDIMA"). Alcoa has been receiving the federal subsidy since the 2006 tax year related to the aforementioned postretirement benefit plans. Under the MPDIMA, the federal subsidy did not reduce an employer's income tax deduction for the costs of providing such prescription drug plans nor was it subject to income tax individually.

Under the Acts, beginning in 2013, an employer's income tax deduction for the costs of providing Medicare Part D-equivalent prescription drug benefits to retirees will be reduced by the amount of the federal subsidy. Under GAAP, any impact from a change in tax law must be recognized in earnings in the period enacted regardless of the effective date. As a result, Alcoa recognized a noncash charge of $79 in 2010 for the elimination of a related deferred tax asset to reflect the change in the tax treatment of the federal subsidy.

 

The components of net deferred tax assets and liabilities were as follows:

 

     2011      2010  
December 31,   

Deferred

tax
assets

   

Deferred

tax
liabilities

    

Deferred

tax
assets

   

Deferred

tax
liabilities

 

Depreciation

   $ 74      $ 933       $ 204      $ 1,330   

Employee benefits

     2,668        51         2,383        45   

Loss provisions

     325        9         391        40   

Deferred income/expense

     45        181         104        159   

Tax loss carryforwards

     2,035        -         1,953        -   

Tax credit carryforwards

     477        -         503        -   

Derivatives and hedging activities

     109        43         162        12   

Other

     315        288         633        547   
     6,048        1,505         6,333        2,133   

Valuation allowance

     (1,398     -         (1,268     -   
     $ 4,650      $ 1,505       $ 5,065      $ 2,133   

The following table details the expiration periods of the deferred tax assets presented above:

December 31, 2011   

Expires

within

10 years

   

Expires

within

11-20 years

   

No

expiration*

    Other*     Total  

Tax loss carryforwards

   $ 340      $ 815      $ 880      $ -      $ 2,035   

Tax credit carryforwards

     360        58        59        -        477   

Other

     -        -        507        3,029        3,536   

Valuation allowance

     (231     (643     (213     (311     (1,398
     $ 469      $ 230      $ 1,233      $ 2,718      $ 4,650   

The total deferred tax asset (net of valuation allowance) is supported by taxable temporary differences that reverse within the carryforward period (approximately 25%), tax planning strategies (approximately 5%), and projections of future taxable income exclusive of reversing temporary differences (approximately 70%).

Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. In evaluating the need for a valuation allowance, management considers all potential sources of taxable income, including income available in carryback periods, future reversals of taxable temporary differences, projections of taxable income, and income from tax planning strategies, as well as all available positive and negative evidence. Positive evidence includes factors such as a history of profitable operations, projections of future profitability within the carryforward period, including from tax planning strategies, and the Company's experience with similar operations. Existing favorable contracts and the ability to sell product into established markets are additional positive evidence. Negative evidence includes items such as cumulative losses, projections of future losses, or carryforward periods that are not long enough to allow the utilization of the deferred tax asset based on existing projections of income. In certain jurisdictions, deferred tax assets related to cumulative losses exist without a valuation allowance where in management's judgment the weight of the positive evidence more than offsets the negative evidence of the cumulative losses. Upon changes in facts and circumstances, management may conclude that deferred tax assets for which no valuation allowance is currently recorded may not be realizable in future periods, resulting in a future charge to record a valuation allowance. Existing valuation allowances are re-examined under the same standards of positive and negative evidence. If it is determined that it is more likely than not that a deferred tax asset will be realized, the appropriate amount of the valuation allowance, if any, is released. Deferred tax assets and liabilities are also re-measured to reflect changes in underlying tax rates due to law changes and the granting and lapse of tax holidays.

In December 2011, one of the Company's subsidiaries in Brazil applied for a tax holiday related to its expanded mining and refining operations. If approved, the tax rate for this subsidiary will decrease significantly, resulting in future cash tax savings over the 10-year holiday period (would be effective as of January 1, 2012). Additionally, the net deferred tax asset of the subsidiary would be remeasured at the lower rate in the period the holiday is approved. This remeasurement would result in a decrease to the net deferred tax asset and a noncash charge to earnings of approximately $60 to $90.

The following table details the changes in the valuation allowance:

 

December 31,    2011     2010  

Balance at beginning of year

   $ 1,268      $ 1,345   

Increase to allowance

     157        25   

Release of allowance*

     (25     (90

Acquisitions/Divestitures

     -        (3

Foreign currency translation

     (2     (9

Balance at end of year

   $ 1,398      $ 1,268   

The cumulative amount of Alcoa's foreign undistributed net earnings for which no deferred taxes have been provided was approximately $8,300 at December 31, 2011. Management has no plans to distribute such earnings in the foreseeable future. It is not practical to determine the deferred tax liability on these earnings.

Alcoa and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. With a few minor exceptions, Alcoa is no longer subject to income tax examinations by tax authorities for years prior to 2002. All U.S. tax years prior to 2011 have been audited by the Internal Revenue Service. Various state and foreign jurisdiction tax authorities are in the process of examining Alcoa's income tax returns for various tax years through 2009.

A reconciliation of the beginning and ending amount of unrecognized tax benefits (excluding interest and penalties) was as follows:

 

December 31,    2011     2010     2009  

Balance at beginning of year

   $ 46      $ 48      $ 24   

Additions for tax positions of the current year

     -        -        1   

Additions for tax positions of prior years

     13        30        24   

Reductions for tax positions of prior years

     (3     (5     -   

Settlements with tax authorities

     (4     (22     (5

Expiration of the statute of limitations

     -        (5     -   

Foreign currency translation

     (1     -        4   

Balance at end of year

   $ 51      $ 46      $ 48   

For all periods presented, a portion of the balance at end of year pertains to state tax liabilities, which are presented before any offset for federal tax benefits. The effect of unrecognized tax benefits, if recorded, that would impact the annual effective tax rate for 2011, 2010, and 2009 would be approximately 2%, 4%, and 1%, respectively, of pretax book income. Alcoa does not anticipate that changes in its unrecognized tax benefits will have a material impact on the Statement of Consolidated Operations during 2012.

 

It is Alcoa's policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes on the accompanying Statement of Consolidated Operations. In 2011, 2010, and 2009, Alcoa recognized $2, $1, and $6, respectively, in interest and penalties. Due to the expiration of the statute of limitations and settlements with tax authorities, Alcoa also recognized income of $2, $4, and $1 in 2011, 2010, and 2009, respectively, related to previously accrued interest and penalties. As of December 31, 2011 and 2010, the amount accrued for the payment of interest and penalties was $12 and $13, respectively.